Pre-treatment with hydration and electrolytes may prevent dose limiting toxicities during foscarnet induction therapy.
作者信息
Jayaweera D, White G, Moreno J
出版信息
Genitourin Med. 1995 Dec;71(6):414-5. doi: 10.1136/sti.71.6.414-a.
Abstract
摘要
相似文献
1
Pre-treatment with hydration and electrolytes may prevent dose limiting toxicities during foscarnet induction therapy.在膦甲酸钠诱导治疗期间，预先进行水化和电解质处理可能预防剂量限制性毒性。
Genitourin Med. 1995 Dec;71(6):414-5. doi: 10.1136/sti.71.6.414-a.
2
Crystallization after intravitreous foscarnet injections.玻璃体内注射膦甲酸钠后的结晶现象。
Arch Ophthalmol. 2012 May;130(5):658-9. doi: 10.1001/archophthalmol.2011.1836.
3
4
CMV retinitis: a clinical management update.巨细胞病毒性视网膜炎：临床管理最新进展
AIDS Patient Care STDS. 1996 Apr;10(2):86-93. doi: 10.1089/apc.1996.10.86.
5
Cytomegalovirus retinitis: new developments in prophylaxis and therapy.巨细胞病毒性视网膜炎：预防与治疗的新进展
AIDS Clin Rev. 1997:249-69.
6
Comparison of pharmacokinetics and dynamics of two dosage regimens of foscarnet in AIDS patients with Cytomegalovirus retinitis.艾滋病合并巨细胞病毒性视网膜炎患者中膦甲酸钠两种给药方案的药代动力学和药效学比较。
Eur J Clin Pharmacol. 1997;52(5):397-401. doi: 10.1007/s002280050308.
7
Foscarnet-induced electrolyte abnormalities in a bone marrow transplant patient receiving parenteral nutrition.接受肠外营养的骨髓移植患者中由膦甲酸引起的电解质异常。
JPEN J Parenter Enteral Nutr. 2000 May-Jun;24(3):170-3. doi: 10.1177/0148607100024003170.
8
Minimising the dosage-limiting toxicities of foscarnet induction therapy.尽量减少膦甲酸诱导疗法的剂量限制性毒性。
Drug Saf. 1997 Apr;16(4):258-66. doi: 10.2165/00002018-199716040-00003.
9
Nephrogenic diabetes insipidus and renal tubular acidosis secondary to foscarnet therapy.膦甲酸钠治疗继发的肾性尿崩症和肾小管酸中毒。
Am J Kidney Dis. 1996 Mar;27(3):431-4. doi: 10.1016/s0272-6386(96)90369-8.
10
Advances in treatment for cytomegalovirus retinitis.巨细胞病毒性视网膜炎的治疗进展
BETA. 1995 Sep:13-5.
引用本文的文献
1
Comparative tolerability of therapies for cytomegalovirus retinitis.巨细胞病毒性视网膜炎治疗方法的耐受性比较
Drug Saf. 1999 Sep;21(3):203-24. doi: 10.2165/00002018-199921030-00005.
2
Minimising the dosage-limiting toxicities of foscarnet induction therapy.尽量减少膦甲酸诱导疗法的剂量限制性毒性。
Drug Saf. 1997 Apr;16(4):258-66. doi: 10.2165/00002018-199716040-00003.
本文引用的文献
1
Effect of foscarnet therapy on human immunodeficiency virus p24 antigen levels in AIDS patients with cytomegalovirus retinitis.膦甲酸钠治疗对患有巨细胞病毒性视网膜炎的艾滋病患者人类免疫缺陷病毒p24抗原水平的影响。
J Infect Dis. 1992 Sep;166(3):607-10. doi: 10.1093/infdis/166.3.607.
Zotero 插件